BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37228445)

  • 1. Resveratrol Loaded by Folate-Modified Liposomes Inhibits Osteosarcoma Growth and Lung Metastasis via Regulating JAK2/STAT3 Pathway.
    Zhu WT; Zeng XF; Yang H; Jia ML; Zhang W; Liu W; Liu SY
    Int J Nanomedicine; 2023; 18():2677-2691. PubMed ID: 37228445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin encapsulated in folic acid-modified liposomes is therapeutic against osteosarcoma by non-covalent binding to the JH2 domain of JAK2 Via the JAK2-STAT3-PDL1.
    Jing D; Wu W; Chen X; Xiao H; Zhang Z; Chen F; Zhang Z; Liu J; Shao Z; Pu F
    Pharmacol Res; 2022 Aug; 182():106287. PubMed ID: 35671921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telocinobufagin inhibits osteosarcoma growth and metastasis by inhibiting the JAK2/STAT3 signaling pathway.
    Ma X; Xu W; Jin X; Mu H; Wang Z; Hua Y; Cai Z; Zhang T
    Eur J Pharmacol; 2023 Mar; 942():175529. PubMed ID: 36690054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition.
    Peng L; Jiang D
    PLoS One; 2018; 13(10):e0205918. PubMed ID: 30356255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway.
    Liu Y; Wang L; Wu Y; Lv C; Li X; Cao X; Yang M; Feng D; Luo Z
    Toxicology; 2013 Feb; 304():120-31. PubMed ID: 23313376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.
    Liu W; Long Q; Zhang W; Zeng D; Hu B; Liu S; Chen L
    Aging (Albany NY); 2021 Aug; 13(15):19760-19775. PubMed ID: 34388111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2/STAT3 Signaling Pathway.
    Jia F; Liu Y; Dou X; Du C; Mao T; Liu X
    Oxid Med Cell Longev; 2022; 2022():8245614. PubMed ID: 35116094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/JAK2/STAT3 signaling axis.
    Pradhan R; Paul S; Acharya SS; Sinha S; Dash SR; Kundu CN
    J Nutr Biochem; 2024 Mar; 125():109568. PubMed ID: 38185347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloroquine suppresses proliferation and invasion and induces apoptosis of osteosarcoma cells associated with inhibition of phosphorylation of STAT3.
    Chen C; Zhang H; Yu Y; Huang Q; Wang W; Niu J; Lou J; Ren T; Huang Y; Guo W
    Aging (Albany NY); 2021 Jun; 13(13):17901-17913. PubMed ID: 34170850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway.
    Park KR; Yun HM; Quang TH; Oh H; Lee DS; Auh QS; Kim EC
    Oncotarget; 2016 Feb; 7(6):6960-71. PubMed ID: 26755649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody.
    He J; Zhang W; Di T; Meng J; Qi Y; Li G; Zhang Y; Su H; Yan W
    Biomed Pharmacother; 2020 Nov; 131():110541. PubMed ID: 33152901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HA-DOPE-Modified Honokiol-Loaded Liposomes Targeted Therapy for Osteosarcoma.
    Zhang X; Chen H; Zhang Y; Huang Q; Feng J; Xing H; Fu X; Yan X; Zhang Y; Xu Q; Liang J
    Int J Nanomedicine; 2022; 17():5137-5151. PubMed ID: 36345507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway.
    Huang L; Huang Z; Lin W; Wang L; Zhu X; Chen X; Yang S; Lv C
    Int J Oncol; 2019 Jun; 54(6):1969-1980. PubMed ID: 31081055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the JAK2/STAT3 signaling pathway exerts a therapeutic effect on osteosarcoma.
    Yan J; Wang Q; Zou K; Wang L; Schwartz EB; Fuchs JR; Zheng Z; Wu J
    Mol Med Rep; 2015 Jul; 12(1):498-502. PubMed ID: 25760445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-parvifuran inhibits metastatic and invasive actions through the JAK2/STAT3 pathway in osteosarcoma cells.
    Yun HM; Park KR; Quang TH; Oh H; Hong JT; Kim YC; Kim EC
    Arch Pharm Res; 2017 May; 40(5):601-609. PubMed ID: 28386742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bruceine D inhibits tumor growth and stem cell-like traits of osteosarcoma through inhibition of STAT3 signaling pathway.
    Wang S; Hu H; Zhong B; Shi D; Qing X; Cheng C; Deng X; Zhang Z; Shao Z
    Cancer Med; 2019 Dec; 8(17):7345-7358. PubMed ID: 31631559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid liposomes inhibit tumor growth and lung metastasis of murine osteosarcoma cells.
    Kitajima H; Komizu Y; Ichihara H; Goto K; Ueoka R
    Cancer Med; 2013 Jun; 2(3):267-76. PubMed ID: 23930203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate-conjugated human serum albumin-encapsulated resveratrol nanoparticles: preparation, characterization, bioavailability and targeting of liver tumors.
    Lian B; Wu M; Feng Z; Deng Y; Zhong C; Zhao X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):154-165. PubMed ID: 30686050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pectolinarigenin acts as a potential anti-osteosarcoma agent via mediating SHP-1/JAK2/STAT3 signaling.
    Zhang T; Li S; Li J; Yin F; Hua Y; Wang Z; Wang H; Zuo D; Xu J; Cai Z
    Biomed Pharmacother; 2022 Sep; 153():113323. PubMed ID: 35752008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoscale polysaccharide derivative as an AEG-1 siRNA carrier for effective osteosarcoma therapy.
    Wang F; Pang JD; Huang LL; Wang R; Li D; Sun K; Wang LT; Zhang LM
    Int J Nanomedicine; 2018; 13():857-875. PubMed ID: 29467575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.